Ecrins Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ecrins Therapeutics SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10642
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company offers products such as native and labeled tubulin, tubulin polymerization kit, monoclonal antibodies, and others. It provides In vitro services such as In vitro tubulin polymerization assay, Growth inhibition assay, In vitro angiogenesis assay, Cytoskeleton staining assay and Custom production of Monoclonal Antibodies, among others. Ecrins provides In vivo services such as In vivo angiogenesis assay and subcutaneous tumor models. Ecrins is headquartered in Grenoble, France.

Ecrins Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ecrins Therapeutics Raises Funds in Venture Financing 10
Ecrins Therapeutics Raises USD0.7 Million in Venture Financing 11
Licensing Agreements 12
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 12
Ecrins Therapeutics SAS – Key Competitors 13
Ecrins Therapeutics SAS – Key Employees 14
Ecrins Therapeutics SAS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Key Facts 2
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ecrins Therapeutics SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ecrins Therapeutics Raises Funds in Venture Financing 10
Ecrins Therapeutics Raises USD0.7 Million in Venture Financing 11
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 12
Ecrins Therapeutics SAS, Key Competitors 13
Ecrins Therapeutics SAS, Key Employees 14

List of Figures
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ecrins Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ecrins Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Power International Development Ltd (2380):電力:M&Aディール及び事業提携情報
    Summary China Power International Development Ltd (China Power) is a conventional energy business of State Power Investment Corp., carries out generation and sales of electricity. The company invests, develops, constructs, owns, operates and manages power plants in Mainland China. It has interests i …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • Bessemer Venture Partners:企業のM&A・事業提携・投資動向
    Bessemer Venture Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bessemer Venture Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Dottikon ES Holding AG (DESN):企業の財務・戦略的SWOT分析
    Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Surgical Care Affiliates LLC:医療機器:M&Aディール及び事業提携情報
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • Firestone Diamonds Plc:企業の戦略・SWOT・財務分析
    Firestone Diamonds Plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hino Motors Ltd (7205):企業の財務・戦略的SWOT分析
    Hino Motors Ltd (7205) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • ManpowerGroup, Inc.:企業の戦略・SWOT・財務情報
    ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Clay Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Clay Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Iconix Brand Group Inc (ICON):企業の財務・戦略的SWOT分析
    Iconix Brand Group Inc (ICON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • Edison International:企業の戦略・SWOT・財務情報
    Edison International - Strategy, SWOT and Corporate Finance Report Summary Edison International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Steppe Cement Ltd:企業の戦略・SWOT・財務情報
    Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report Summary The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Gestamp Renewable Industries:電力:M&Aディール及び事業提携情報
    Summary Gestamp Renewable Industries, a subsidiary of Corporacion Gestamp SL, is a renewable energy service provider. The company offers development, promotion, construction and operation of electric generation power plants from biomass. It offers production, logistics, packaging, generation, design …
  • Dayton Superior Corp:企業の戦略的SWOT分析
    Dayton Superior Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆